NASDAQ: KYTX
Kyverna Therapeutics Inc Stock Ownership - Who owns Kyverna Therapeutics?

Insider buying vs selling

Have Kyverna Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Beth C. SeidenbergDirector2025-12-18133,333$7.50
$1,000.00kBuy
Westlake Biopartners Opportunity Fund I LP10% Owner2025-12-18133,333$7.50
$1,000.00kBuy
Karen Marie WalkerChief Technology Officer2025-12-1523,998$4.83
$115.91kBuy
Karen Marie WalkerChief Technology Officer2025-12-1523,998$12.20
$292.78kSell

1 of 1

KYTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KYTX insiders and whales buy or sell their stock.

KYTX Shareholders

What type of owners hold Kyverna Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vida Ventures LLC10.91%4,777,060$42.04MInsider
Fred E. Cohen10.37%4,540,558$39.96MInsider
Gordonmd Global Investments LP10.03%4,391,818$38.65MInstitution
Gilead Sciences Inc9.42%4,126,119$36.31MInstitution
Gilead Sciences Inc9.42%4,126,119$36.31MInsider
Beth C. Seidenberg8.69%3,804,574$33.48MInsider
Westlake Biopartners Opportunity Fund I LP8.65%3,787,940$33.33MInsider
Northpond Ventures III GP LLC7.43%3,255,426$28.65MInsider
Bain Capital Life Sciences Investors LLC7.22%3,163,868$27.84MInsider
Bain Capital Life Sciences Investors LLC7.10%3,110,000$27.37MInstitution

1 of 3

KYTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KYTX53.71%46.29%Net Buying
LCTX39.96%60.04%Net SellingNet Selling
DMAC23.15%71.44%Net BuyingNet Buying
GLSI9.23%90.77%Net BuyingNet Buying
CADL32.27%24.06%Net BuyingNet Buying

Kyverna Therapeutics Stock Ownership FAQ

Who owns Kyverna Therapeutics?

Kyverna Therapeutics (NASDAQ: KYTX) is owned by 77.93% institutional shareholders, 67.18% Kyverna Therapeutics insiders, and 0.00% retail investors. Vida Ventures LLC is the largest individual Kyverna Therapeutics shareholder, owning 4.78M shares representing 10.91% of the company. Vida Ventures LLC's Kyverna Therapeutics shares are currently valued at $40.80M.

If you're new to stock investing, here's how to buy Kyverna Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.